These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 351694)

  • 21. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
    Kyank HR
    Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A scoring system for the assessment of multiple methods of monitoring fetal growth.
    Robinson HP; Chatfield WR; Logan RW; Tweedie AK; Barnard WP
    J Obstet Gynaecol Br Commonw; 1973 Mar; 80(3):230-5. PubMed ID: 4703261
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oxytocinase in feto-placental insufficiency].
    Mansani FE; Condemi V; Ceruti M; Serventi G
    Ann Ostet Ginecol Med Perinat; 1977; 98(4):221-40. PubMed ID: 907282
    [No Abstract]   [Full Text] [Related]  

  • 25. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies.
    Ronin-Walknowska E; Holmgren PA; von Schoultz B; Stigbrand T
    Gynecol Obstet Invest; 1984; 18(4):206-11. PubMed ID: 6510780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Feto-placental system in diabetes mellitus and hydramnios].
    Savchenko ON; Kosheleva NG; Iartseva MA; Golumb SB; Stepanov GS
    Akush Ginekol (Mosk); 1991 Dec; (12):12-5. PubMed ID: 1789335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma human placental lactogen, oxytocinase, and placental phosphatase in normal and toxemic pregnancies.
    Spellacy WN; Usategui-Gomez M; Fernandez-deCastro A
    Am J Obstet Gynecol; 1977 Jan; 127(1):10-6. PubMed ID: 188338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maternal serum levels of cystine-aminopeptidase (C.A.P.) in normal and pathological pregnancies (author's transl)].
    Thoumsin HJ; Loos AB; Krausch C; Lambotte R
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(8):849-54. PubMed ID: 7217635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum heat-stable alkaline phosphatase. In normal and high-risk pregnancies.
    Marshall BR; Parisi F
    Obstet Gynecol; 1975 Feb; 45(2):136-41. PubMed ID: 1118083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of certain enzymological studies in the evaluation of placental function].
    Kamiński K; Krupa B; Kaźmierczak W
    Wiad Lek; 1979 Sep; 32(18):1315-8. PubMed ID: 116427
    [No Abstract]   [Full Text] [Related]  

  • 31. Human placental lactogen levels in high risk pregnancies.
    Spellacy WN; Teoh ES
    Surg Forum; 1969; 20():409-10. PubMed ID: 5383103
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum oxytocinase: an index of placental function].
    Tiriduzzi M
    Minerva Ginecol; 1977; 29(7-8):557-62. PubMed ID: 337182
    [No Abstract]   [Full Text] [Related]  

  • 34. Placental function tests by blood analysis.
    Bhansali KG
    J Natl Med Assoc; 1975 Mar; 67(2):137-9. PubMed ID: 805842
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypertension in pregnancy (author's transl)].
    Zander J; Goebel R; Kuhn W
    MMW Munch Med Wochenschr; 1974 Apr; 116(14):699-706. PubMed ID: 4209132
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal serum HPL levels in normal and complicated pregnancy as an index of placental function.
    Ylikorkala O
    Acta Obstet Gynecol Scand Suppl; 1973; 26():1-52. PubMed ID: 4522254
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of curves for prediction of maternal blood levels of placenta-specific substances for diagnosis of placental function.
    Yamaguchi R; Ueda H; Shimozato N; Tsuji Y; Amano A
    Tohoku J Exp Med; 1979 Jul; 128(3):201-7. PubMed ID: 315114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation.
    Hensleigh PA; Cheatum SG; Spellacy WN
    Am J Obstet Gynecol; 1977 Nov; 129(6):675-8. PubMed ID: 920768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cystine aminopeptidase, total and placental leucine aminopeptidase in pathological pregnancies (author's transl)].
    Nesit V; Pĕtros J
    Cesk Gynekol; 1981 Aug; 46(7):506-20. PubMed ID: 7285172
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development of levels of chorionic somatomommotropic hormone during high risk pregnancies].
    Gaspard U; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):324-7. PubMed ID: 4681535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.